Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Am J Cardiol. 2013 May 29;112(5):700–706. doi: 10.1016/j.amjcard.2013.04.046

Table 1.

Demographic, clinical, and echocardiographic characteristics by baseline 6-minute walk test performance

Variable Unable to Walk Slow Walkers Fast Walkers p Value
Age (yrs) 84.6 (79.1–88.9) 85.9 (81.7–88.5) 83.6 (78.3–87.6) 0.01
Male gender 98 (45%) 73 (55%) 89 (67%) 0.0003
Body mass index (kg/m2) 26.2 (22.7–30.4) 26.0 (22.1–30.2) 25.5 (22.8–29.0) 0.60
Transfemoral TAVI 180 (83%) 104 (78%) 103 (77%) 0.43
STS Score 11.4 (10.0–14.0) 11.1 (9.4–14.0) 10.5 (8.8–12.0) 0.001
Diabetes mellitus 90 (41%) 46 (35%) 56 (42%) 0.37
Hypertension 193 (89%) 116 (87%) 119 (90%) 0.83
Angina pectoris 45 (21%) 37 (28%) 37 (28%) 0.19
Heart failure 216 (99%) 130 (98%) 128 (96%) 0.19
NYHA Class IV 118 (54%) 64 (48%) 60 (45%) 0.23
CAD 148 (68%) 96 (72%) 103 (77%) 0.15
Previous PCI 61 (28%) 45 (34%) 39 (29%) 0.53
Previous coronary bypass 78 (36%) 46 (35%) 64 (48%) 0.04
Cerebrovascular disease 59 (29%) 32 (26%) 43 (34%) 0.37
Peripheral vascular disease 91 (42%) 49 (37%) 47 (36%) 0.47
Previous BAV 32 (15%) 23 (17%) 8 (6%) 0.01
Permanent pacemaker 37 (17%) 37 (29%) 25 (19%) 0.04
Renal disease 41 (19%) 24 (18%) 23 (17%) 0.94
Liver disease 5 (2%) 1 (1%) 8 (6%) 0.03
Oxygen-dependent COPD 41 (19%) 15 (11%) 10 (8%) 0.007
AV mean gradient (mm Hg) 41.9 (32.5–53.3) 40.4 (33.0–51.2) 41.3 (33.3–49.2) 0.67
AV area (EOA) (cm2) 0.63 (0.51–0.76) 0.63 (0.53–0.73) 0.66 (0.56–0.79) 0.26
Ejection fraction (%) 55.4 (44.4–61.7) 53.0 (37.6–61.3) 57.5 (48.5–64.4) 0.06
Severe mitral regurgitation 3 (1%) 6 (5%) 6 (5%) 0.14

AV = aortic valve; BAV = balloon aortic valvuloplasty; BMI = body mass index; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; EOA = effective orifice area; NYHA = New York Heart Association; PCI = percutaneous coronary intervention; STS = Society of Thoracic Surgery; TAVI = transcatheter aortic valve implantation.